Skip to main content

Table 1 Baseline characteristics of the study patients

From: Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study

 

Transplant group (n = 36)

Control group (n = 126)

p

Demographic data

 Age (years)

58.3 ± 1.6

72.6 ± 1.1

<0.001

 Male sex, n (%)

26 (72 %)

79 (63 %)

0.33

Cardiovascular risk factors

 Diabetes mellitus, n (%)

14 (39 %)

73 (58 %)

0.025

 Hypertension, n (%)

33 (92 %)

108 (86 %)

0.16

 Current smoking, n (%)

14 (39 %)

60 (48 %)

0.12

 Hypercholesterolemia, n (%)

30 (83 %)

104 (83 %)

0.15

 Body mass index (kg/m2)

25.2 ± 0.8

27.2 ± 0.5

0.05

Biological data

 eGFR (MDRD formula) (mL/min/1.73 m2)

47.9 ± 3.7

39.5 ± 2.9

0.15

 Anemia (Hb <12.5 g/dL), n (%)

17 (47 %)

68 (54 %)

0.47

 CRP (mg/dL)

7.6 ± 1.5

25.4 ± 4.1

0.02

  1. Data are expressed as means ± SD or counts (percentages), as appropriate. Abbreviations: eGFR estimated glomerular filtration rate, MDRD modification of diet in renal disease, Hb hemoglobin, CRP C-reactive protein